Earmark - Noninvasive Vectored Vaccine Research

Agency:		Department of Defense--Military
Bureau:		Research, Development, Test, and Evaluation
Account:		Research, development, test, and evaluation, Navy (17-1319)
Certifying Official:		Deputy Comptroller Program/Budget
Contact Information:		http://WWW.DOD.GOV 703-697-5131

Noninvasive Vectored Vaccine Research

1 recipient will receive $1,209,000. This is a continuing earmark.

Year Enacted: 2005

Description: To Pursue technology to vaccinate people by placing a vectored vaccine on the surface of the skin. Needles are not required to administer the vaccine and the person being vaccinated is not subjected to the pain of needle injection. Development work to be conducted by Vaxin and the University of Alabama, Birmingham (UAB) will allow several new, topical vaccines to be produced and tested over the course of the next two years.

Beneficiary/Recipient	Amount ($K)	Program	Type	Address
VAXIN Inc.	$1,209		For-Profit	Birmingham, AL

Citation

Source: Appropriations Report Language - Conference

Reference: 108-622

Location: Line 130, Page 303

Citation Excerpt: Noninvasive Vectored Vaccine Research

Last Modified: 16-Apr-2007